Ajanta Pharma Limited

BSE:532331 Stock Report

Market Cap: ₹348.2b

Ajanta Pharma Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Yogesh Agrawal

Chief executive officer

₹216.0m

Total compensation

CEO salary percentage57.2%
CEO tenure17.2yrs
CEO ownership14.5%
Management average tenureno data
Board average tenure6.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Yogesh Agrawal's remuneration changed compared to Ajanta Pharma's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2024n/an/a

₹9b

Sep 30 2024n/an/a

₹9b

Jun 30 2024n/an/a

₹9b

Mar 31 2024₹216m₹124m

₹8b

Dec 31 2023n/an/a

₹7b

Sep 30 2023n/an/a

₹7b

Jun 30 2023n/an/a

₹6b

Mar 31 2023₹156m₹112m

₹6b

Dec 31 2022n/an/a

₹6b

Sep 30 2022n/an/a

₹7b

Jun 30 2022n/an/a

₹7b

Mar 31 2022₹163m₹94m

₹7b

Dec 31 2021n/an/a

₹7b

Sep 30 2021n/an/a

₹7b

Jun 30 2021n/an/a

₹7b

Mar 31 2021₹128m₹75m

₹7b

Dec 31 2020n/an/a

₹6b

Sep 30 2020n/an/a

₹6b

Jun 30 2020n/an/a

₹5b

Mar 31 2020₹107m₹66m

₹5b

Dec 31 2019n/an/a

₹4b

Sep 30 2019n/an/a

₹4b

Jun 30 2019n/an/a

₹4b

Mar 31 2019₹99m₹61m

₹4b

Dec 31 2018n/an/a

₹4b

Sep 30 2018n/an/a

₹5b

Jun 30 2018n/an/a

₹5b

Mar 31 2018₹44m₹13m

₹5b

Compensation vs Market: Yogesh's total compensation ($USD2.49M) is above average for companies of similar size in the Indian market ($USD594.52K).

Compensation vs Earnings: Yogesh's compensation has increased by more than 20% in the past year.

CEO

Yogesh Agrawal (52 yo)

17.2yrs

Tenure

₹215,960,000

Compensation

Mr. Yogesh Mannalal Agrawal, M.B.A, has been Managing Director at Ajanta Pharma Ltd. since December 14, 2007. Mr. Agrawal is handling global business of Ajanta Pharma Ltd.He has handled various aspects of...

Board Members

NamePositionTenureCompensationOwnership
Yogesh Agrawal
MD & Executive Director24.8yrs₹215.96m14.48%
₹ 50.4b
Rajesh Agrawal
Joint MD & Director11.8yrs₹215.96m27.48%
₹ 95.7b
Madhusudan Agrawal
Executive Vice Chairman of the Board27.2yrs₹42.04mno data
Ramesh Jhawar
Director of Ajanta Pharma USA Inc.no data₹25.50mno data
Mannalal Agrawal
Chairman of the Board45.2yrs₹777.00kno data
David Rasquinha
Independent Non-Executive Directorless than a yearno datano data
Medha Joshi
Independent Non-Executive Directorless than a yearno datano data
Sam Gioskos
Director of Ajanta Pharma Philippines Inc.no datano datano data
Suttian Deerpaul
Director of Ajanta Pharma (Mauritius) Ltd.no datano datano data
Vinayak Muzumdar
Director of Ajanta Pharma (Mauritius) Ltd.no datano datano data
Rajesh Dalal
Independent Non-Executive Directorless than a yearno datano data
Simi Thapar
Independent Non-Executive Directorless than a yearno datano data

6.3yrs

Average Tenure

68yo

Average Age

Experienced Board: 532331's board of directors are considered experienced (6.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/19 22:15
End of Day Share Price 2025/02/19 00:00
Earnings2024/12/31
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Ajanta Pharma Limited is covered by 26 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Rashmi Sancheti ShettyAnand Rathi Shares and Stock Brokers Limited
null nullAnand Rathi Shares and Stock Brokers Limited
null nullAsian Markets Securities Private Limited